https://www.formularywatch.com/view/what-we-re-reading-counterfeit-ozempic2024-06-06T18:32:32.655Z2024-06-06T18:32:32.655Z https://www.formularywatch.com/view/fda-committee-concerned-about-bias-votes-no-on-psychedelic-in-ptsd2024-06-05T15:07:53.311Z2024-06-05T15:07:53.311Z https://www.formularywatch.com/view/fda-approves-moderna-s-rsv-vaccine2024-06-03T12:12:59.905Z2024-06-03T12:12:59.905Z https://www.formularywatch.com/view/fda-sets-goal-date-for-resubmitted-zolbetuximab-in-gastric-cancer2024-06-01T13:00:00.000Z2024-06-01T13:00:00.000Z https://www.formularywatch.com/view/lucyrx-partners-with-employers-for-a-new-kind-of-pbm2024-05-31T17:10:53.709Z2024-05-31T17:10:53.709Z https://www.formularywatch.com/view/fda-delays-decision-for-dupixent-in-copd2024-05-31T13:12:43.680Z2024-05-31T13:12:43.680Z https://www.formularywatch.com/view/fda-approves-breyanzi-for-mantel-cell-lymphoma2024-05-31T11:54:24.076Z2024-05-31T11:54:24.076Z https://www.formularywatch.com/view/fda-approves-non-stimulant-adhd-medication2024-05-30T15:56:09.586Z2024-05-30T15:56:09.586Z https://www.formularywatch.com/view/fda-sets-date-for-zanidatamab-in-bile-duct-cancer2024-05-29T21:59:20.795Z2024-05-29T21:59:20.795Z https://www.formularywatch.com/view/fda-assigns-review-date-for-inavolisib-in-metastatic-breast-cancer2024-05-29T17:57:52.364Z2024-05-29T17:57:52.364Z https://www.formularywatch.com/view/fda-approves-first-interchangeable-biosimilar-of-soliris2024-05-29T12:12:33.323Z2024-05-29T12:12:33.323Z https://www.formularywatch.com/view/global-spending-on-cancer-drugs-to-increase-to-409-billion2024-05-28T17:47:39.363Z2024-05-28T17:47:39.363Z https://www.formularywatch.com/view/verastem-begins-submission-for-ovarian-cancer-combination2024-05-24T14:16:14.879Z2024-05-24T14:16:14.879Z https://www.formularywatch.com/view/fda-approves-first-interchangeable-biosimilars-to-eylea2024-05-21T13:12:30.198Z2024-05-21T13:12:30.198Z https://www.formularywatch.com/view/optum-rx-to-offer-guarantee-based-pricing-model2024-05-20T19:56:37.125Z2024-05-20T19:57:04.441Z https://www.formularywatch.com/view/atara-submits-bla-for-cell-therapy-for-post-transplant-complication2024-05-20T14:48:47.923Z2024-05-20T14:48:47.923Z https://www.formularywatch.com/view/fda-approves-bispecific-antibody-for-small-cell-lung-cancer2024-05-17T13:51:25.932Z2024-05-17T13:51:25.932Z https://www.formularywatch.com/view/fda-approves-breyanzi-for-follicular-lymphoma2024-05-16T14:12:17.132Z2024-05-16T14:12:17.132Z https://www.formularywatch.com/view/biogen-eisai-begin-submission-of-subcutaneous-leqembi2024-05-15T13:04:34.581Z2024-05-15T13:04:34.581Z https://www.formularywatch.com/view/fda-sets-review-date-for-gene-therapy-for-enzyme-deficiency2024-05-14T15:08:39.283Z2024-05-14T15:08:39.283Z https://www.formularywatch.com/view/boehringer-ingelheim-is-second-company-to-provide-private-label-humira-biosimilar-to-evernorth2024-05-14T11:44:28.577Z2024-05-14T11:44:28.577Z https://www.formularywatch.com/view/administrative-issues-delay-fda-decision-on-moderna-rsv-vaccine2024-05-10T17:42:50.220Z2024-05-10T17:42:50.220Z https://www.formularywatch.com/view/kff-1-in-8-adults-have-used-glp-1-agonists2024-05-10T14:19:47.211Z2024-05-10T14:19:47.211Z https://www.formularywatch.com/view/orladeyo-can-reduce-health-resource-use-in-hae2024-05-09T18:15:28.147Z2024-05-09T18:15:28.147Z https://www.formularywatch.com/view/investigational-anticoagulant-may-be-cost-effective2024-05-08T18:55:47.505Z2024-05-08T20:37:58.718Z https://www.formularywatch.com/view/fda-sets-date-for-advisory-committee-meeting-for-midomafetamine-for-ptsd2024-05-08T11:53:26.453Z2024-05-08T11:53:26.453Z https://www.formularywatch.com/view/fda-accepts-bla-for-pancreatic-and-lung-cancer-therapy2024-05-07T20:03:42.653Z2024-05-07T20:03:42.653Z https://www.formularywatch.com/view/fda-sets-date-of-advisory-committee-meeting-for-donanemab-in-alzheimer-s-disease2024-05-07T17:45:39.619Z2024-05-07T17:45:39.619Z https://www.formularywatch.com/view/iqvia-medicine-spending-expected-to-grow-4-to-7-by-20282024-05-07T16:24:59.979Z2024-05-07T16:24:59.979Z https://www.formularywatch.com/view/fda-approves-liquid-mycophenolate-to-prevent-organ-rejections2024-05-06T19:22:28.886Z2024-05-06T19:22:28.886Z https://www.formularywatch.com/view/fda-assigns-action-date-for-subcutaneous-opdivo2024-05-06T12:59:26.420Z2024-05-06T12:59:26.420Z https://www.formularywatch.com/view/survey-managing-total-of-cost-of-care-is-top-priority2024-05-03T18:13:51.782Z2024-05-03T18:13:51.782Z https://www.formularywatch.com/view/alvotech-to-manufacture-interchangeable-humira-biosimilar-for-teva-and-quallent2024-05-01T11:13:14.362Z2024-05-01T11:13:14.362Z https://www.formularywatch.com/view/fda-converts-tivdak-s-accelerated-approval-to-full-approval-for-cervical-cancer2024-04-30T14:11:28.142Z2024-04-30T14:11:28.142Z https://www.formularywatch.com/view/what-we-re-reading-more-on-cigna-s-reviews-of-claims2024-04-30T13:17:55.674Z2024-04-30T13:17:55.674Z https://www.formularywatch.com/view/express-scripts-adds-zymfentra-to-national-preferred-formulary2024-04-29T14:59:33.941Z2024-04-29T14:59:33.941Z https://www.formularywatch.com/view/fda-approves-xolremdi-for-ultra-rare-immune-disorder2024-04-29T14:29:18.150Z2024-04-29T14:29:18.150Z https://www.formularywatch.com/view/fda-approves-libervant-film-for-epilepsy-in-young-children2024-04-29T12:50:02.211Z2024-04-29T12:50:02.211Z https://www.formularywatch.com/view/fda-approves-pfizer-s-gene-therapy-for-beqvez-for-hemophilia2024-04-26T12:58:12.002Z2024-04-26T12:58:12.002Z https://www.formularywatch.com/view/walgreens-to-offer-cell-and-gene-therapy-services2024-04-26T11:01:15.897Z2024-04-26T11:01:15.897Z https://www.formularywatch.com/view/evernorth-to-offer-private-label-humira-biosimilar2024-04-25T21:01:02.227Z2024-04-25T21:01:02.227Z https://www.formularywatch.com/view/fda-approves-ojemda-for-children-with-brain-tumors2024-04-25T15:41:15.776Z2024-04-25T15:41:15.776Z https://www.formularywatch.com/view/no-silver-bullet-for-paying-for-gene-therapies2024-04-24T18:36:16.999Z2024-04-24T18:36:16.999Z https://www.formularywatch.com/view/discoloration-leads-to-recall-of-sapropterin-products2024-04-24T13:19:46.780Z2024-04-24T13:19:46.780Z https://www.formularywatch.com/view/fda-approves-lutathera-for-adolescents-with-neuroendocrine-tumors2024-04-23T21:19:52.023Z2024-04-23T21:19:52.023Z https://www.formularywatch.com/view/fda-approves-bladder-cancer-immunotherapy2024-04-23T14:51:56.113Z2024-04-23T14:51:56.113Z https://www.formularywatch.com/view/fda-issues-complete-response-letter-for-pz-cel-to-treat-epidermolysis-bullosa2024-04-22T21:07:55.835Z2024-04-22T21:07:55.835Z https://www.formularywatch.com/view/par-recalls-more-treprostinil-due-to-silicone-in-the-product2024-04-22T12:44:51.258Z2024-04-22T12:44:51.258Z https://www.formularywatch.com/view/fda-approves-pen-form-of-entyvio-for-crohn-s-disease2024-04-19T15:13:23.716Z2024-04-19T15:13:23.716Z https://www.formularywatch.com/view/fda-approves-stelara-biosimilar-selarsdi2024-04-18T15:37:25.702Z2024-04-18T15:37:25.702Z https://www.formularywatch.com/view/most-cancer-drugs-with-accelerated-approval-don-t-show-benefit2024-04-18T12:37:03.507Z2024-04-18T12:37:03.507Z https://www.formularywatch.com/view/fda-approves-gsk-s-bla-for-5-in-1-meningococcal-vaccine2024-04-17T11:59:26.218Z2024-04-17T11:59:26.218Z https://www.formularywatch.com/view/kff-some-medicaid-beneficiaries-are-uninsured-after-being-disenrolled2024-04-12T18:59:43.436Z2024-04-12T18:59:43.436Z https://www.formularywatch.com/view/payers-recognize-the-benefits-but-still-see-weight-loss-drugs-through-a-cost-lens2024-04-12T13:11:27.107Z2024-04-12T13:11:27.107Z https://www.formularywatch.com/view/fasenra-approved-for-children-with-severe-asthma2024-04-11T13:56:00.383Z2024-04-11T13:56:00.383Z https://www.formularywatch.com/view/drugs-to-watch-mental-health-conditions2024-04-11T13:00:00.000Z2024-04-11T13:00:00.000Z https://www.formularywatch.com/view/ventegra-launches-point-of-sale-rebate-program2024-04-10T18:27:08.318Z2024-04-10T18:27:08.318Z https://www.formularywatch.com/view/drugs-to-watch-lung-cancer2024-04-10T14:39:23.063Z2024-04-10T14:39:23.063Z https://www.formularywatch.com/view/fda-issues-second-crl-for-parkinson-s-therapy2024-04-08T18:49:29.108Z2024-04-08T18:49:29.108Z https://www.formularywatch.com/view/humira-biosimilars-have-a-slow-uptake-finds-samsung-bioepis-report2024-04-08T15:11:13.689Z2024-04-08T15:11:13.689Z https://www.formularywatch.com/view/tuft-s-joshua-cohen-talks-about-quality-adjusted-life-years2024-04-05T20:06:09.844Z2024-04-05T20:06:09.844Z https://www.formularywatch.com/view/amylyx-pulls-als-treatment-off-market-with-a-few-thousand-still-on-treatment-as-of-late-232024-04-05T15:31:05.427Z2024-04-05T15:31:05.427Z https://www.formularywatch.com/view/fda-accepts-supplemental-bla-for-bimzelx-in-hidradenitis-suppurativa2024-04-04T16:25:31.561Z2024-04-04T16:25:31.561Z https://www.formularywatch.com/view/fda-approves-zevtera-for-serious-bacterial-infections2024-04-03T21:50:33.639Z2024-04-03T21:50:33.639Z https://www.formularywatch.com/view/avera-health-plans-selects-scripius-as-its-pbm2024-04-03T17:11:52.137Z2024-04-03T17:11:52.137Z https://www.formularywatch.com/view/fda-approves-fanapt-for-bipolar-12024-04-03T15:02:47.100Z2024-04-03T15:02:47.100Z https://www.formularywatch.com/view/potential-contamination-leads-to-recall-of-atovaquone2024-04-02T19:52:47.472Z2024-04-02T19:52:47.472Z https://www.formularywatch.com/view/ira-is-expected-to-cut-out-of-pocket-costs-by-28-for-women-in-medicare2024-04-02T17:06:26.385Z2024-04-02T17:06:26.385Z https://www.formularywatch.com/view/fda-approves-voydeya-as-add-on-therapy-in-rare-blood-disorder2024-04-01T14:38:05.580Z2024-04-01T14:38:05.580Z https://www.formularywatch.com/view/amneal-recalls-4-lots-of-vancomycin-because-of-overfilling2024-03-29T13:19:13.919Z2024-03-29T13:19:13.919Z https://www.formularywatch.com/view/icer-to-shine-a-light-on-clinical-trial-diversity2024-03-28T20:47:12.720Z2024-03-28T20:47:12.720Z https://www.formularywatch.com/view/fda-approves-vemlidy-for-children-with-hepatitis-b2024-03-28T17:14:34.279Z2024-03-28T17:14:34.279Z https://www.formularywatch.com/view/fda-approves-vafseo-for-anemia-in-kidney-disease2024-03-28T12:57:30.599Z2024-03-28T12:57:30.599Z https://www.formularywatch.com/view/medicare-s-spending-on-ozempic-and-other-glp-1s-rise-steeply2024-03-27T19:55:09.141Z2024-03-27T19:55:09.141Z https://www.formularywatch.com/view/alliancerx-walgreens-pharmacy-selected-to-distribute-vivjoy2024-03-27T15:30:15.092Z2024-03-27T15:30:15.092Z https://www.formularywatch.com/view/fda-approves-merck-s-drug-for-pulmonary-arterial-hypertension2024-03-26T23:59:54.516Z2024-03-26T23:59:54.516Z https://www.formularywatch.com/view/cms-estimates-savings-for-patients-from-medicare-inflation-rebates2024-03-26T18:06:43.054Z2024-03-26T18:06:43.054Z https://www.formularywatch.com/view/fda-approves-combination-therapy-for-pulmonary-arterial-hypertension2024-03-25T17:25:31.587Z2024-03-25T17:25:31.587Z https://www.formularywatch.com/view/fda-issues-crl-for-odronextamab-for-lymphoma-indications2024-03-25T14:50:51.680Z2024-03-25T14:50:51.680Z https://www.formularywatch.com/view/fda-grants-full-approval-to-elahere2024-03-25T12:42:47.818Z2024-03-25T12:42:47.818Z https://www.formularywatch.com/view/medicaid-medicare-part-d-to-provide-coverage-of-wegovy-but-not-for-weight-loss2024-03-22T16:31:58.625Z2024-03-22T16:31:58.625Z https://www.formularywatch.com/view/fda-approves-nonsteroidal-drug-for-duchenne2024-03-22T12:29:48.635Z2024-03-22T12:29:48.635Z https://www.formularywatch.com/view/gsk-caps-respiratory-medications-at-35-a-month2024-03-21T16:16:23.733Z2024-03-21T16:16:23.733Z https://www.formularywatch.com/view/fda-approves-drug-that-treats-hypertension-in-a-new-way2024-03-21T12:01:11.596Z2024-03-21T12:01:11.596Z https://www.formularywatch.com/view/new-gene-for-rare-mdl-to-cost-4-25-million2024-03-20T12:57:15.013Z2024-03-20T12:57:15.013Z https://www.formularywatch.com/view/celltrion-launches-zymfentra-a-subcutaneous-form-of-infliximab2024-03-20T11:47:05.335Z2024-03-20T11:47:05.335Z https://www.formularywatch.com/view/fda-approves-iclusig-for-new-patients-with-aggressive-leukemia2024-03-19T19:41:24.768Z2024-03-19T19:41:24.768Z https://www.formularywatch.com/view/payers-question-cms-ability-to-get-discounts-though-drug-price-negotiation2024-03-19T14:37:54.154Z2024-03-19T14:37:54.154Z https://www.formularywatch.com/view/fda-approves-gene-therapy-for-rare-disease-mdl2024-03-18T18:57:58.574Z2024-03-18T18:57:58.574Z https://www.formularywatch.com/view/fda-sets-action-date-for-resubmitted-lymphir-in-rare-skin-cancer2024-03-18T16:27:34.921Z2024-03-18T16:27:34.921Z https://www.formularywatch.com/view/astrazeneca-to-cap-asthma-and-copd-meds-at-35-a-month2024-03-18T11:58:53.245Z2024-03-18T11:58:53.245Z https://www.formularywatch.com/view/fda-approves-tevimbra-for-esophageal-cancer2024-03-15T18:24:22.561Z2024-03-15T18:24:22.561Z https://www.formularywatch.com/view/fda-approves-breyanzi-for-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2024-03-15T16:44:44.651Z2024-03-15T16:44:44.651Z https://www.formularywatch.com/view/fda-approves-rezdiffra-first-drug-for-nash2024-03-15T12:08:57.930Z2024-03-15T12:08:57.930Z https://www.formularywatch.com/view/fda-approves-livmarli-for-second-liver-disease-indication2024-03-14T14:27:52.886Z2024-03-14T14:27:52.886Z https://www.formularywatch.com/view/silicone-particles-in-product-leads-to-recall-of-treprostinil2024-03-14T11:50:22.015Z2024-03-14T11:50:22.015Z https://www.formularywatch.com/view/prime-therapeutics-and-capital-rx-create-technology-alliance2024-03-13T19:25:31.283Z2024-03-13T19:25:31.283Z https://www.formularywatch.com/view/spending-on-children-s-mental-health-conditions-increases-study-finds2024-03-13T17:53:38.078Z2024-03-13T17:53:38.078Z https://www.formularywatch.com/view/fda-approves-praluent-for-children-with-genetic-form-of-high-cholesterol2024-03-12T11:46:00.428Z2024-03-12T11:46:00.428Z https://www.formularywatch.com/view/fda-issues-crl-for-monthly-ms-drug2024-03-11T16:00:06.017Z2024-03-11T16:00:06.017Z